Ian Tracy

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response.

Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response.

Journal: Molecular cancer

Published: September 20, 2024

Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.

Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.

Journal: The EMBO journal

Published: May 11, 2024

Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.

Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.

Journal: Research square

Published: March 18, 2024

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells.

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells.

Journal: Clinical epigenetics

Published: July 03, 2023

High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.

High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.

Journal: Blood advances

Published: November 23, 2021

Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients.

Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 25, 2018

STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.

STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.

Journal: Cancer research

Published: October 12, 2016

Type C TP53-CDKN1A pathway dysfunction occurs independently of CDKN1A gene polymorphisms in chronic lymphocytic leukaemia and is associated with TP53 abnormalities.

Type C TP53-CDKN1A pathway dysfunction occurs independently of CDKN1A gene polymorphisms in chronic lymphocytic leukaemia and is associated with TP53 abnormalities.

Journal: British journal of haematology

Published: June 14, 2016

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.

Journal: Blood

Published: March 28, 2016

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors.

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors.

Journal: British journal of haematology

Published: April 15, 2014

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.

Journal: British journal of haematology

Published: December 17, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026